Ludhiana (Punjab) [India], June 5: Anmol India Ltd. (BSE: 542437, NSE: ANMOL), one of the leading players in Supply chain management industry, Commodity Trading, and Coal Import, has approved issue of bonus shares in the ratio of 4:1, i.e. 4 Equity Shares for every 1 Equity Share held by the
The results were announced on May 25, following approval of the IUCN's bid evaluation committee recommendations to the IUCN Governing Council at its meeting held in Gland, Switzerland from May 23rd-25th 2023.
According to a recent investigation by Nikkei Asia, China deliberately delays clearances, which prevents corporations like Japan's Nippon Telegraph and Telephone, Singapore Telecommunications, and the US internet titans Meta and Google from implementing their undersea cable projects, accordi
The approval enables India to play active role at multilateral organisations in the postal sector with emphasis on South-South and Triangular cooperation.
Mumbai (Maharashtra) [India], May 31: SGS is proud to announce that it's Health Science laboratory based in Navi Mumbai has received the approval of the World Health Organization (Geneva) - Prequalification Unit (PQT) for testing, analytical services, and stability studies.
Bangalore (Karnataka)/ New Delhi [India], May 31: Constantia Flexibles, Premji Invest and Amit Banga, Managing Director of SB Packagings, have finalized the joint venture to create one of the largest sustainable packaging platforms in India and South Asia, following the regulatory approval f
The Union Cabinet, chaired by Prime Minister Narendra Modi, on May 17 had given approval to introduce the scheme and it was notified on Monday. The PLI Scheme 2.0 for IT Hardware was approved with a budgetary outlay of Rs 17,000 crore.
Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval
Approval of the PDA for the hydel project to be undertaken in Eastern Nepal comes ahead of Nepal PM Pushpa Kamal Dahal's India visit which is set to start from Wednesday.
According to a statement from the Ministry of Health and Family Welfare, the supplementary approval of Rs 652.13 crore for fiscal 2022-23 and Rs 1,618.54 crore for fiscal 2023-24 is approved for Maharashtra.
In a tweet, Neuralink expressed its excitement, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first